Free Trial

Thermo Fisher Scientific (TMO) Competitors

Thermo Fisher Scientific logo
$478.60 +3.58 (+0.75%)
Closing price 03:59 PM Eastern
Extended Trading
$474.00 -4.61 (-0.96%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TMO vs. MEDP, A, AMN, DHR, HAE, MCK, QGEN, WST, MTD, and WAT

Should you be buying Thermo Fisher Scientific stock or one of its competitors? The main competitors of Thermo Fisher Scientific include Medpace (MEDP), Agilent Technologies (A), AMN Healthcare Services (AMN), Danaher (DHR), Haemonetics (HAE), McKesson (MCK), Qiagen (QGEN), West Pharmaceutical Services (WST), Mettler-Toledo International (MTD), and Waters (WAT). These companies are all part of the "medical" sector.

Thermo Fisher Scientific vs. Its Competitors

Thermo Fisher Scientific (NYSE:TMO) and Medpace (NASDAQ:MEDP) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

Thermo Fisher Scientific presently has a consensus target price of $593.00, suggesting a potential upside of 23.90%. Medpace has a consensus target price of $411.10, suggesting a potential downside of 8.13%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, equities research analysts plainly believe Thermo Fisher Scientific is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Thermo Fisher Scientific
0 Sell rating(s)
5 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.75
Medpace
2 Sell rating(s)
10 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00

Thermo Fisher Scientific has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, Medpace has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500.

Medpace has a net margin of 18.74% compared to Thermo Fisher Scientific's net margin of 15.24%. Medpace's return on equity of 67.66% beat Thermo Fisher Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Thermo Fisher Scientific15.24% 16.82% 8.38%
Medpace 18.74%67.66%21.86%

89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by company insiders. Comparatively, 20.3% of Medpace shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Thermo Fisher Scientific had 52 more articles in the media than Medpace. MarketBeat recorded 92 mentions for Thermo Fisher Scientific and 40 mentions for Medpace. Thermo Fisher Scientific's average media sentiment score of 0.92 beat Medpace's score of 0.76 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Thermo Fisher Scientific
49 Very Positive mention(s)
16 Positive mention(s)
11 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Medpace
12 Very Positive mention(s)
8 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Thermo Fisher Scientific has higher revenue and earnings than Medpace. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Thermo Fisher Scientific$42.88B4.21$6.34B$17.0528.07
Medpace$2.23B5.76$404.39M$13.4533.27

Summary

Thermo Fisher Scientific beats Medpace on 9 of the 16 factors compared between the two stocks.

Get Thermo Fisher Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMO vs. The Competition

MetricThermo Fisher ScientificMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$180.67B$7.00B$5.74B$21.13B
Dividend Yield0.37%1.28%4.60%3.58%
P/E Ratio27.6825.5128.1127.87
Price / Sales4.2166.31461.3759.63
Price / Cash15.5420.6736.5523.02
Price / Book3.584.758.654.69
Net Income$6.34B$176.14M$3.25B$995.51M
7 Day Performance15.25%2.92%4.20%1.64%
1 Month Performance16.61%3.56%10.82%5.92%
1 Year Performance-19.49%7.66%34.70%11.50%

Thermo Fisher Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMO
Thermo Fisher Scientific
4.9533 of 5 stars
$478.61
+0.8%
$593.00
+23.9%
-17.3%$180.67B$42.88B27.68125,000Trending News
Earnings Report
Analyst Forecast
Analyst Revision
MEDP
Medpace
3.7039 of 5 stars
$310.14
-0.6%
$344.82
+11.2%
+19.3%$8.92B$2.11B23.695,900Trending News
Earnings Report
Analyst Forecast
Analyst Revision
Gap Down
A
Agilent Technologies
4.7471 of 5 stars
$112.86
-1.0%
$139.77
+23.8%
-10.3%$32.08B$6.51B27.8817,900Positive News
AMN
AMN Healthcare Services
4.2089 of 5 stars
$18.45
-6.9%
$32.08
+73.9%
-68.2%$710.86M$2.98B-4.292,968
DHR
Danaher
4.8284 of 5 stars
$189.18
-0.5%
$248.48
+31.3%
-23.5%$135.50B$23.88B36.7663,000Trending News
Earnings Report
Analyst Forecast
Analyst Revision
HAE
Haemonetics
4.9308 of 5 stars
$74.10
+2.1%
$97.30
+31.3%
-18.9%$3.56B$1.36B22.393,023Positive News
MCK
McKesson
4.6048 of 5 stars
$711.34
+0.2%
$710.17
-0.2%
+20.4%$89.04B$359.05B27.5545,000Positive News
QGEN
Qiagen
3.7097 of 5 stars
$48.21
-0.3%
$49.40
+2.5%
+25.6%$10.73B$1.98B120.975,765Positive News
Analyst Revision
WST
West Pharmaceutical Services
4.4708 of 5 stars
$210.97
+0.0%
$320.00
+51.7%
-13.9%$15.16B$2.89B33.1310,600Trending News
Earnings Report
Dividend Increase
Analyst Forecast
MTD
Mettler-Toledo International
4.1324 of 5 stars
$1,173.27
-1.8%
$1,280.90
+9.2%
-8.8%$24.41B$3.87B29.2917,300Positive News
Upcoming Earnings
WAT
Waters
4.8358 of 5 stars
$282.77
-1.7%
$381.94
+35.1%
-2.3%$16.85B$2.96B25.697,600Trending News
High Trading Volume

Related Companies and Tools


This page (NYSE:TMO) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners